Cargando…
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
Chagas’ disease is an endemic disease in Latin America caused by a unicellular parasite (Trypanosoma cruzi) that affects almost 18 million people. This condition involves the heart, causing heart failure, arrhythmias, heart block, thromboembolism, stroke, and sudden death. In this article, we review...
Autores principales: | Muratore, Claudio A, Baranchuk, Adrian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922320/ https://www.ncbi.nlm.nih.gov/pubmed/20730015 |
Ejemplares similares
-
Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012) -
Analysis of Iron Metabolism in Chronic Chagasic
Cardiomyopathy
por: Miranda, Carla Paixão, et al.
Publicado: (2019) -
Left Atrial Function in Patients with Chronic Chagasic
Cardiomyopathy
por: Fragata, Claudia da Silva, et al.
Publicado: (2015) -
Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015) -
Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)